ERBB2 and breast carcinoma: The chief objectives of the study were to evaluate the patients with breast carcinoma in terms of their age, history, clinical stage, histological grade, and hormone receptors (estrogen receptor (ER), progesterone receptor (PR), and HER2/neu) status, and to compare the data between the two age groups, i.e., old and young.